Angiogenesis in the human corpus luteum

Reproductive Medicine and Biology - 2008
Norihiro Sugino, Aki Matsuoka1, Koichi Taniguchi1, Hiroshi Tamura1
1Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Ube, Japan

Tóm tắt

Angiogenesis is important for the formation and development of the corpus luteum and for maintenance of luteal function. Blood vessel regression is an important physiological phenomenon in the corpus luteum, which is associated with tissue involution during structural luteolysis. Angiogenesis actively occurs during the early luteal phase and is completed by the mid‐luteal phase. Perivascular cells (pericytes) increase in number from the early luteal phase to the mid‐luteal phase, suggesting that blood vessels are gradually stabilized until the mid‐luteal phase. In the corpus luteum undergoing luteolysis, blood vessels and pericytes decrease in number, which is related to structural involution. In the corpus luteum of early pregnancy, the number of blood vessels with pericytes increases, suggesting that angiogenesis occurs again, accompanied by blood vessel stabilization. These changes in vasculature of the corpus luteum are regulated by the collaboration with vascular endothelial growth factor, which is involved in proliferation of vascular endothelial cells, and angiopoietins, which are involved in stabilization of blood vessels. This review focuses on angiogenesis, blood vessel stabilization and blood vessel regression during the divergent phases of luteal formation, luteal regression and luteal rescue by pregnancy. (Reprod Med Biol 2008; 7: 91–103)

Từ khóa


Tài liệu tham khảo

10.1095/biolreprod36.5.1149

10.1038/nm0398-336

10.1210/en.141.3.995

10.1210/jc.85.10.3919

10.1095/biolreprod64.1.317

10.1186/1477-7827-1-88

10.1016/S0188-4409(01)00323-X

10.1007/s10456-005-9004-y

10.1111/j.1439-0531.2004.00505.x

10.1186/1477-7827-1-89

10.1530/rep.0.1210355

10.1385/ENDO:12:1:1

10.1210/jc.2005-0643

Augustin HG, 2000, Morphogenesis of Endothelium, 237

Eberhard A, 2000, Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies, Cancer Res, 60, 1388

10.1210/jc.2005-1199

10.1210/jc.86.7.3377

10.1172/JCI200320087

10.1016/S0301-2115(96)02666-8

10.1093/humrep/13.10.2836

10.1016/j.fertnstert.2003.05.019

10.1016/S0015-0282(16)58209-0

10.1016/S0015-0282(16)57783-8

Kalogirou D, 1997, Transvaginal Doppler ultrasound with color flow imaging in the diagnosis of luteal phase defect (LPD), Clin Exp Obstet Gynecol, 24, 95

10.1016/j.domaniend.2005.03.011

10.1111/j.1447-0578.2005.00086.x

Sugino N., 2005, Roles of reactive oxygen species and superoxide dismutase in the corpus luteum and endometrium, Trends Reprod Biol, 1, 1

10.1111/j.1740-0929.2006.00386.x

10.1262/jrd.19047

10.1210/jc.85.11.4379

Azmi TI, 1984, Mechanism of deletion of endothelial cells during regression of the corpus luteum, Lab Invest, 51, 206

Modlich U, 1996, Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion, Laboratory Invest, 74, 771

Goede V, 1998, Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis, Laboratory Invest, 78, 1385

10.2741/davis1

Christenson LK, 1996, Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy, Endocrinology, 137, 367, 10.1210/endo.137.1.8536637

10.1093/humrep/12.8.1723

10.1093/humrep/13.4.953

10.1093/humrep/15.3.557

10.1095/biolreprod60.4.914

10.1093/humrep/16.12.2515

10.1095/biolreprod67.4.1180

10.1126/science.277.5322.48

10.1038/35025215

10.1172/JCI6127

10.1016/S0092-8674(00)81813-9

10.1038/74725

10.1016/S0079-6107(02)00037-8

Kaczmarek MM, 2005, Role of vascular endothelial growth factor in ovarian physiology – an overview, Reprod Biol, 5, 111

10.1210/en.2004-0765

10.1126/science.277.5322.55

10.1093/molehr/6.11.993

10.1210/jc.81.1.353

10.1210/en.131.1.254

10.1210/jcem.84.10.6025

10.1016/S0015-0282(01)02012-X

10.1210/en.138.11.4748

10.1210/jc.2005-2457

10.1530/rep.0.1220875

10.1210/jc.80.6.1967

10.1210/jc.2002-020642

Dickson SE, 2000, Inhibition of early luteal angiogenesis by gonadotropin‐releasing hormone antagonist treatment in the primate, J Clin Endocrinol Metab, 85, 2339, 10.1210/jcem.85.6.6621

10.1006/jmcc.1996.0365

10.1074/jbc.273.21.13313

10.1210/jc.85.11.4302

10.1038/35091000

10.1016/S0002-9440(10)64322-2

10.1210/jc.2004-0843

10.1093/humrep/13.8.2180

10.1210/en.141.7.2648

10.1210/en.2006-1687

10.1095/biolreprod.106.053934

10.1172/JCI5028

10.1530/rep.1.00947

10.1126/science.282.5388.468

10.1126/science.286.5449.2511

10.1038/376070a0

10.1016/S0002-9440(10)64242-3

10.1016/j.bbrc.2003.09.111

10.1002/jgm.439

10.1046/j.1469-7580.2002.00061.x

TamuraH TakasakiA TaniguchiK MatsuokaA ShimamuraK SuginoN.Changes in blood flow impedance of the human corpus luteum throughout the luteal phase and during early pregnancy.Fertil Steril(in press).

10.1530/rep.1.01064

Thông tin
Thông tin xuất bản

Reproductive Medicine and Biology

Thông tin tác giả